Desloratadine 5 mg tablets ,Aerius 5 mg tablets
Sponsors
Bio-innova Co., Ltd.
Conditions
Healthy subjects
Bioequivalence Desloratadine 5 mg tabletsHealthy subjects
Bioequivalence Desloratadine 5 mg tablets
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Desloratadine 5 mg tablets relative to Aerius 5 mg tablets in healthy Thai volunteers under fasting condition
TCTR20230811009
Start: 2023-10-24Target: 26Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Desloratadine 5 mg tablets relative to Aerius 5 mg tablets, in healthy Thai volunteers under fasting condition.
TCTR20240427007
Start: 2025-01-09Target: 26Updated: 2026-08-03